首页 > 最新文献

Health Policy and Technology最新文献

英文 中文
A cross-sectional study regarding the knowledge, attitude and awareness about self-medication among Bangladeshi people 关于孟加拉人自我药疗的知识、态度和意识的横断面研究
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-08-01 DOI: 10.1016/j.hlpt.2022.100715
Md. Abu Bakar Siddique Jami , Kushal Biswas

Background

Self-medication is the use of medicinal products by the consumer which is not prescribed by a doctor. Self-medication practice (SMP) is widely adopted by the common people of developing countries like Bangladesh.

Methods

It was a cross-sectional study. Primary data were collected by conducting an online survey. Data collection was carried out from April 2021 to September 2021. The subjects were a minimum of 15 years of age. From 35 districts of Bangladesh, a total of 322 people of different age groups, education levels, and economic classes participated in the survey.

Result

71% (229) of the respondents were 21-25 years of age. 66% were undergraduate students. Most of them were from middle class society and well-educated. 80% of the population said that they had purchased or taken medicines without any prescription. 57% of them said they do not consider self-medication a very safe practice although, 87% of the population had practiced self-medication at least once in the preceding year. Antipyretics (212), Analgesics (165), Drugs for Cold/Cough (197) and Anti-ulcer/Antacids (140) were the majority categories of medicines that were used mostly for self-medication. Nearly all (311) of them collect SMP medicine from pharmacy shops. Previous prescriptions (146), advice from family or friends (165) and Internet or other media (113) were common sources of information for their self-medication practice.

Conclusion

Self-medication practice is highly prevalent in Bangladesh. People are not aware enough about the possible negative outcomes of it. Therefore, regulatory laws should be implemented more strictly regarding buying and selling medicines.

Lay Summary

The rate of self-medication practice appears to be increasing in Bangladesh, due to a number of socioeconomic and lifestyle factors that include ready access to drugs, increased potential to manage certain illnesses through self- care, and greater availability of medicinal products. Self-medication is not only prevalent in Bangladesh, it is present at a catastrophic rate. This article shows the overall awareness level of people regarding SMP and other health issues, which medicines are commonly being bought by people and their sources of information.
背景:自我用药是指消费者在没有医生处方的情况下使用药品。自我药疗实践(SMP)被孟加拉国等发展中国家的普通民众广泛采用。方法采用横断面研究。主要数据是通过在线调查收集的。数据收集于2021年4月至2021年9月进行。受试者年龄至少为15岁。来自孟加拉国35个地区,共有322名不同年龄、教育水平和经济阶层的人参与了调查。结果71%(229人)的调查对象年龄在21 ~ 25岁之间。66%为本科生。他们大多来自中产阶级,受过良好的教育。80%的人说他们没有处方就购买或服用了药物。其中57%的人说他们不认为自我药疗是一种非常安全的做法,尽管87%的人在前一年至少进行过一次自我药疗。退烧药(212)、镇痛药(165)、感冒药/止咳药(197)和抗溃疡/抗酸药(140)是自我用药的主要类别。几乎全部(311人)从药店领取SMP药品。以前的处方(146人)、家人或朋友的建议(165人)和互联网或其他媒体(113人)是他们自我用药实践的常见信息来源。结论自我药疗在孟加拉国非常普遍。人们对它可能带来的负面后果没有足够的认识。因此,应该更严格地执行有关药品买卖的监管法律。由于一些社会经济和生活方式因素,包括随时获得药物,通过自我保健管理某些疾病的可能性增加,以及药品的可获得性增加,孟加拉国的自我药疗实践率似乎正在增加。自我药疗不仅在孟加拉国很普遍,而且以灾难性的速度出现。本文显示了人们对SMP和其他健康问题的总体认识水平,人们通常购买哪些药物及其信息来源。
{"title":"A cross-sectional study regarding the knowledge, attitude and awareness about self-medication among Bangladeshi people","authors":"Md. Abu Bakar Siddique Jami ,&nbsp;Kushal Biswas","doi":"10.1016/j.hlpt.2022.100715","DOIUrl":"10.1016/j.hlpt.2022.100715","url":null,"abstract":"<div><h3>Background</h3><div>Self-medication is the use of medicinal products by the consumer which is not prescribed by a doctor. Self-medication practice (SMP) is widely adopted by the common people of developing countries like Bangladesh.</div></div><div><h3>Methods</h3><div>It was a cross-sectional study. Primary data were collected by conducting an online survey. Data collection was carried out from April 2021 to September 2021. The subjects were a minimum of 15 years of age. From 35 districts of Bangladesh, a total of 322 people of different age groups, education levels, and economic classes participated in the survey.</div></div><div><h3>Result</h3><div>71% (229) of the respondents were 21-25 years of age. 66% were undergraduate students. Most of them were from middle class society and well-educated. 80% of the population said that they had purchased or taken medicines without any prescription. 57% of them said they do not consider self-medication a very safe practice although, 87% of the population had practiced self-medication at least once in the preceding year. Antipyretics (212), Analgesics (165), Drugs for Cold/Cough (197) and Anti-ulcer/Antacids (140) were the majority categories of medicines that were used mostly for self-medication. Nearly all (311) of them collect SMP medicine from pharmacy shops. Previous prescriptions (146), advice from family or friends (165) and Internet or other media (113) were common sources of information for their self-medication practice.</div></div><div><h3>Conclusion</h3><div>Self-medication practice is highly prevalent in Bangladesh. People are not aware enough about the possible negative outcomes of it. Therefore, regulatory laws should be implemented more strictly regarding buying and selling medicines.</div></div><div><h3>Lay Summary</h3><div>The rate of self-medication practice appears to be increasing in Bangladesh, due to a number of socioeconomic and lifestyle factors that include ready access to drugs, increased potential to manage certain illnesses through self- care, and greater availability of medicinal products. Self-medication is not only prevalent in Bangladesh, it is present at a catastrophic rate. This article shows the overall awareness level of people regarding SMP and other health issues, which medicines are commonly being bought by people and their sources of information.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 4","pages":"Article 100715"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144827288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adoption of contact tracing app during pandemic: Users’ resistance behavior 在大流行病期间采用联系人追踪应用程序:用户的抵制行为
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-08-01 DOI: 10.1016/j.hlpt.2024.100901
Yogesh Bhatt , Karminder Ghuman , Safiya Mukhtar Alshibani , Usama Awan

Objectives

The study investigates the key issues influencing different barriers resulting in user resistance toward adopting contact tracing smartphone apps launched to track COVID-19 infections.

Methods

Indian users’ experiences regarding the Aarogya Setu app for preventing the spread of COVID-19 were examined in two phases. In Phase I, online users’ comments available at the Google Play Store were qualitatively analyzed using open and axial coding. These codes were then used to create an implication matrix and hierarchical value maps to illustrate and interpret the relationships between issues, barriers, and user behavior. In Phase II, a supplementary empirical study, data was collected from users and non-users of the app through semi-structured telephone interviews and then qualitatively analyzed.

Results

By drawing on innovation resistance theory, the current study mapped a set of adoption barriers with three types of user resistance, i.e., postponement, opposition, and rejection. Rejection emerged as the most prominent consumer resistance behavior; usage barriers, functional risk, and value barriers related to the app's usage were the key drivers of this behavior. Postponement was the second most observed consumer resistance behavior. If usage barriers, functional risk, and value barriers of the app resulted in functional barriers toward adoption of the app, then image barrier was the key reason behind the psychological barrier.

Conclusion

Administrators and developers of future interventions need to be conscious of usage barriers, functional risks, and value barriers related to the app's usage through stakeholder engagement to secure broader and faster adoption of such apps to improve health information systems.
本研究调查了影响用户采用为追踪 COVID-19 感染而推出的接触追踪智能手机应用程序的不同障碍的关键问题。研究分两个阶段考察了印度用户对用于预防 COVID-19 传播的 Aarogya Setu 应用程序的体验。在第一阶段,我们使用开放式和轴向编码对 Google Play 商店中的在线用户评论进行了定性分析。然后,利用这些编码创建了影响矩阵和分层价值图,以说明和解释问题、障碍和用户行为之间的关系。第二阶段是补充性实证研究,通过半结构化电话访谈从应用程序的用户和非用户那里收集数据,然后进行定性分析。通过借鉴创新阻力理论,本研究将一系列采用障碍与三种类型的用户阻力(即推迟、反对和拒绝)进行了映射。拒绝是最突出的消费者抵制行为;与应用程序使用相关的使用障碍、功能风险和价值障碍是这一行为的主要驱动因素。推迟是第二大消费者抵制行为。如果说应用程序的使用障碍、功能风险和价值障碍导致了采用应用程序的功能障碍,那么形象障碍则是心理障碍背后的关键原因。未来干预措施的管理者和开发者需要通过利益相关者的参与,意识到与应用程序使用相关的使用障碍、功能风险和价值障碍,以确保更广泛、更快速地采用此类应用程序来改善医疗信息系统。
{"title":"Adoption of contact tracing app during pandemic: Users’ resistance behavior","authors":"Yogesh Bhatt ,&nbsp;Karminder Ghuman ,&nbsp;Safiya Mukhtar Alshibani ,&nbsp;Usama Awan","doi":"10.1016/j.hlpt.2024.100901","DOIUrl":"10.1016/j.hlpt.2024.100901","url":null,"abstract":"<div><h3>Objectives</h3><div>The study investigates the key issues influencing different barriers resulting in user resistance toward adopting contact tracing smartphone apps launched to track COVID-19 infections.</div></div><div><h3>Methods</h3><div>Indian users’ experiences regarding the Aarogya Setu app for preventing the spread of COVID-19 were examined in two phases. In Phase I, online users’ comments available at the Google Play Store were qualitatively analyzed using open and axial coding. These codes were then used to create an implication matrix and hierarchical value maps to illustrate and interpret the relationships between issues, barriers, and user behavior. In Phase II, a supplementary empirical study, data was collected from users and non-users of the app through semi-structured telephone interviews and then qualitatively analyzed.</div></div><div><h3>Results</h3><div>By drawing on innovation resistance theory, the current study mapped a set of adoption barriers with three types of user resistance, i.e., postponement, opposition, and rejection. Rejection emerged as the most prominent consumer resistance behavior; usage barriers, functional risk, and value barriers related to the app's usage were the key drivers of this behavior. Postponement was the second most observed consumer resistance behavior. If usage barriers, functional risk, and value barriers of the app resulted in functional barriers toward adoption of the app, then image barrier was the key reason behind the psychological barrier.</div></div><div><h3>Conclusion</h3><div>Administrators and developers of future interventions need to be conscious of usage barriers, functional risks, and value barriers related to the app's usage through stakeholder engagement to secure broader and faster adoption of such apps to improve health information systems.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 4","pages":"Article 100901"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142215669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining the influence of personal eHealth literacy on continuance intention towards mobile health applications: A TAM-based approach 检查个人电子健康素养对移动健康应用程序继续意向的影响:基于tam的方法
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-08-01 DOI: 10.1016/j.hlpt.2025.101024
Oscar Chidiebere Ukaegbu, Mingyue Fan

Objectives

Mobile health applications (MHAs) play a key role in modern healthcare delivery, yet understanding the factors influencing users' continuance intention towards these platforms remains a critical area of inquiry. This study investigates the influence of perceived e-Health literacy (PEHL) on users' trust, perceived usefulness, and perceived ease of use of MHAs, employing the Technology Acceptance Model (TAM) as a theoretical framework.

Methods

Structural equation modeling was employed to evaluate data collected from 430 participants in Nigeria. This approach facilitated a thorough assessment of the complex interconnections among Perceived e-health literacy, Perceived usefulness, perceived ease of use, trust, and Continuance intention of MHAs. Through the application of statistical analyses within this framework, the study aimed to offer a rigorous examination of the data and extract significant findings.

Results

Through this survey of MHAs users, path analysis reveals significant positive associations between PEHL and trust, perceived usefulness, and perceived ease of use, underscoring importance regarding individual competencies with shaping views of digital health resources. Moreover, trust emerges as a key mediator in the relationship between PEHL and users' continuance intention to use MHAs, highlighting its pivotal role in fostering sustained engagement with these platforms.

Discussion

The findings highlight the pivotal role of trust in fostering sustained engagement with MHAs. The results suggest that enhancing users' eHealth literacy can positively influence their trust and perceptions of usefulness and ease of use, which in turn can drive their intention to continue using these applications.

Conclusions

The study contributes to theoretical advancements in eHealth literature and offers practical insights for the design and implementation of MHAs to enhance user acceptance and engagement in digital healthcare ecosystems. The positive associations identified between PEHL, trust, and continuance intention underscore the need for strategies that enhance users' competencies and trust to ensure sustained use of MHAs.
目的移动医疗应用(MHAs)在现代医疗服务中发挥着关键作用,但了解影响用户继续使用这些平台意愿的因素仍然是一个关键的研究领域。本研究以技术接受模型(TAM)为理论框架,探讨感知电子健康素养(PEHL)对用户信任、感知有用性和感知易用性的影响。方法采用结构方程模型对尼日利亚430名参与者的数据进行评价。这种方法有助于全面评估感知电子卫生素养、感知有用性、感知易用性、信任和mha的持续意图之间的复杂相互关系。通过在此框架内应用统计分析,本研究旨在对数据进行严格检查并提取重要发现。结果通过对MHAs用户的调查,路径分析揭示了PEHL与信任、感知有用性和感知易用性之间的显著正相关,强调了个人能力在塑造数字卫生资源观点方面的重要性。此外,在PEHL和用户继续使用mha的意愿之间的关系中,信任是一个关键的中介,突出了它在促进与这些平台的持续接触方面的关键作用。研究结果强调了信任在促进与mha的持续接触方面的关键作用。结果表明,提高用户的电子健康素养可以积极影响他们对有用性和易用性的信任和看法,这反过来可以推动他们继续使用这些应用程序的意愿。结论本研究促进了电子医疗文献的理论进步,并为mha的设计和实施提供了实践见解,以提高用户对数字医疗生态系统的接受度和参与度。PEHL、信任和继续使用意愿之间的正相关关系强调了提高用户能力和信任的战略的必要性,以确保mha的持续使用。
{"title":"Examining the influence of personal eHealth literacy on continuance intention towards mobile health applications: A TAM-based approach","authors":"Oscar Chidiebere Ukaegbu,&nbsp;Mingyue Fan","doi":"10.1016/j.hlpt.2025.101024","DOIUrl":"10.1016/j.hlpt.2025.101024","url":null,"abstract":"<div><h3>Objectives</h3><div>Mobile health applications (MHAs) play a key role in modern healthcare delivery, yet understanding the factors influencing users' continuance intention towards these platforms remains a critical area of inquiry. This study investigates the influence of perceived e-Health literacy (PEHL) on users' trust, perceived usefulness, and perceived ease of use of MHAs, employing the Technology Acceptance Model (TAM) as a theoretical framework.</div></div><div><h3>Methods</h3><div>Structural equation modeling was employed to evaluate data collected from 430 participants in Nigeria. This approach facilitated a thorough assessment of the complex interconnections among Perceived e-health literacy, Perceived usefulness, perceived ease of use, trust, and Continuance intention of MHAs. Through the application of statistical analyses within this framework, the study aimed to offer a rigorous examination of the data and extract significant findings.</div></div><div><h3>Results</h3><div>Through this survey of MHAs users, path analysis reveals significant positive associations between PEHL and trust, perceived usefulness, and perceived ease of use, underscoring importance regarding individual competencies with shaping views of digital health resources. Moreover, trust emerges as a key mediator in the relationship between PEHL and users' continuance intention to use MHAs, highlighting its pivotal role in fostering sustained engagement with these platforms.</div></div><div><h3>Discussion</h3><div>The findings highlight the pivotal role of trust in fostering sustained engagement with MHAs. The results suggest that enhancing users' eHealth literacy can positively influence their trust and perceptions of usefulness and ease of use, which in turn can drive their intention to continue using these applications.</div></div><div><h3>Conclusions</h3><div>The study contributes to theoretical advancements in eHealth literature and offers practical insights for the design and implementation of MHAs to enhance user acceptance and engagement in digital healthcare ecosystems. The positive associations identified between PEHL, trust, and continuance intention underscore the need for strategies that enhance users' competencies and trust to ensure sustained use of MHAs.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 4","pages":"Article 101024"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144827287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative approaches to strengthening health systems in LMIC's 加强低收入和中等收入国家卫生系统的创新方法
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-08-01 DOI: 10.1016/j.hlpt.2024.100970
Diana Frost , Mufti Mahmud , M.Shamim Kaiser , David Musoke , Paulette Henry , Shariful Islam
None.
没有。
{"title":"Innovative approaches to strengthening health systems in LMIC's","authors":"Diana Frost ,&nbsp;Mufti Mahmud ,&nbsp;M.Shamim Kaiser ,&nbsp;David Musoke ,&nbsp;Paulette Henry ,&nbsp;Shariful Islam","doi":"10.1016/j.hlpt.2024.100970","DOIUrl":"10.1016/j.hlpt.2024.100970","url":null,"abstract":"<div><div>None.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 4","pages":"Article 100970"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144827290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital health inclusion towards achieving universal health coverage for Bangladesh utilizing general practitioner model 利用全科医生模式实现孟加拉国全民健康覆盖的数字健康包容
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-08-01 DOI: 10.1016/j.hlpt.2023.100731
Moinul H. Chowdhury , Rony Chowdhury Ripan , A.K.M. Nazmul Islam , Rubaiyat Alim Hridhee , Farhana Sarker , Sheikh Mohammed Shariful Islam , Khondaker A. Mamun

Objective

Bangladesh's health care system, particularly in rural areas, experiences enormous obstacles in providing complete preventive and primary healthcare services due to the lack of adequate healthcare facilities, resource constraints, and a non-functional referral system. To alleviate these problems, in this study, we introduce the digital general practitioner (GP) model for rural Bangladesh, digital platforms and present a statistical analysis of the data that was gathered from the pilot project.

Methods

A total of 12,746 people were provided regular health services during the pilot project, from all genders and age groups, and provided their socio-demographic and healthcare-related data. We analyzed healthcare-related data by carrying out both descriptive and inferential statistics.

Results

By utilizing this digital GP model, rural residents can receive routine health screenings at their homes, identify health risks early, receive consultation and health education, and be referred to GP and upper-level health facilities as needed. We found that hypertension was more prevalent (4.84% of the served population), and cancer was the least prevalent of all the NCDs in the studied population (0.05% of the served population). The population for stroke, hypertension, diabetes increased until the 50–59 age range as age increased, following which the population proportion declined as age increased. Additionally, 3.96% of young females were severely malnourished, comparably higher proportion than young males (2.34%).

Conclusion

NCDs such as hypertension, diabetes was prevalent among rural people. Necessary steps should be taken to raise preventive and primary healthcare awareness among rural people.

Public interest summary

The absence of proper healthcare facilities, resource constraints, and a non-functional referral system hamper Bangladesh's health care system's ability to provide comprehensive preventive and primary healthcare services in rural area. As a result, patients develop advanced ailments, including non-communicable diseases (NCDs), and must seek treatment at an expensive specialty hospital. To resolve this issue, we introduce a digital GP model for rural Bangladesh, then show digital platforms that use the concept, and lastly summarize significant findings from the piloted digital GP model. By utilizing this digital GP model, rural residents can receive routine health screenings at their homes, identify health risks early, receive consultation and health education, and be referred to GP and upper-level health facilities as need. From our data analysis, we discovered high burden of NCDs such as hypertension and diabetes in the piloted area. Necessary steps should be taken to raise preventive and primary healthcare awareness among rural people.
孟加拉国的卫生保健系统,特别是在农村地区,在提供完整的预防和初级卫生保健服务方面遇到了巨大的障碍,原因是缺乏足够的卫生保健设施,资源限制,以及功能不健全的转诊系统。为了缓解这些问题,在本研究中,我们为孟加拉国农村引入了数字全科医生(GP)模型、数字平台,并对从试点项目中收集的数据进行了统计分析。方法在试点项目期间,共有来自所有性别和年龄组的12,746人获得了定期保健服务,并提供了他们的社会人口和保健相关数据。我们通过描述性和推断性统计来分析医疗保健相关数据。结果利用数字全科医生模式,农村居民可以在家中进行常规健康筛查,及早发现健康风险,接受咨询和健康教育,并根据需要转诊到全科医生和上级卫生机构。我们发现高血压更为普遍(占服务人群的4.84%),而癌症是所有非传染性疾病中发病率最低的(占服务人群的0.05%)。在50-59岁年龄段,中风、高血压、糖尿病患者的比例随着年龄的增长而增加,随后随着年龄的增长而下降。女性严重营养不良的比例为3.96%,高于男性(2.34%)。结论农村人群中高血压、糖尿病等非传染性疾病较为普遍。应采取必要步骤,提高农村人口对预防和初级保健的认识。由于缺乏适当的卫生保健设施,资源有限,转诊系统功能不全,孟加拉国卫生保健系统无法在农村地区提供全面的预防和初级卫生保健服务。结果,患者患上了晚期疾病,包括非传染性疾病(NCDs),必须在昂贵的专科医院寻求治疗。为了解决这一问题,我们为孟加拉国农村引入了数字全科医生模型,然后展示了使用该概念的数字平台,最后总结了试点数字全科医生模型的重要发现。利用这种数字全科医生模式,农村居民可以在家中接受常规健康检查,及早发现健康风险,接受咨询和健康教育,并根据需要转诊到全科医生和上级卫生机构。通过数据分析,我们发现试点地区高血压、糖尿病等非传染性疾病负担较高。应采取必要步骤,提高农村人口对预防和初级保健的认识。
{"title":"Digital health inclusion towards achieving universal health coverage for Bangladesh utilizing general practitioner model","authors":"Moinul H. Chowdhury ,&nbsp;Rony Chowdhury Ripan ,&nbsp;A.K.M. Nazmul Islam ,&nbsp;Rubaiyat Alim Hridhee ,&nbsp;Farhana Sarker ,&nbsp;Sheikh Mohammed Shariful Islam ,&nbsp;Khondaker A. Mamun","doi":"10.1016/j.hlpt.2023.100731","DOIUrl":"10.1016/j.hlpt.2023.100731","url":null,"abstract":"<div><h3>Objective</h3><div>Bangladesh's health care system, particularly in rural areas, experiences enormous obstacles in providing complete preventive and primary healthcare services due to the lack of adequate healthcare facilities, resource constraints, and a non-functional referral system. To alleviate these problems, in this study, we introduce the digital general practitioner (GP) model for rural Bangladesh, digital platforms and present a statistical analysis of the data that was gathered from the pilot project.</div></div><div><h3>Methods</h3><div>A total of 12,746 people were provided regular health services during the pilot project, from all genders and age groups, and provided their socio-demographic and healthcare-related data. We analyzed healthcare-related data by carrying out both descriptive and inferential statistics.</div></div><div><h3>Results</h3><div>By utilizing this digital GP model, rural residents can receive routine health screenings at their homes, identify health risks early, receive consultation and health education, and be referred to GP and upper-level health facilities as needed. We found that hypertension was more prevalent (4.84% of the served population), and cancer was the least prevalent of all the NCDs in the studied population (0.05% of the served population). The population for stroke, hypertension, diabetes increased until the 50–59 age range as age increased, following which the population proportion declined as age increased. Additionally, 3.96% of young females were severely malnourished, comparably higher proportion than young males (2.34%).</div></div><div><h3>Conclusion</h3><div>NCDs such as hypertension, diabetes was prevalent among rural people. Necessary steps should be taken to raise preventive and primary healthcare awareness among rural people.</div></div><div><h3>Public interest summary</h3><div>The absence of proper healthcare facilities, resource constraints, and a non-functional referral system hamper Bangladesh's health care system's ability to provide comprehensive preventive and primary healthcare services in rural area. As a result, patients develop advanced ailments, including non-communicable diseases (NCDs), and must seek treatment at an expensive specialty hospital. To resolve this issue, we introduce a digital GP model for rural Bangladesh, then show digital platforms that use the concept, and lastly summarize significant findings from the piloted digital GP model. By utilizing this digital GP model, rural residents can receive routine health screenings at their homes, identify health risks early, receive consultation and health education, and be referred to GP and upper-level health facilities as need. From our data analysis, we discovered high burden of NCDs such as hypertension and diabetes in the piloted area. Necessary steps should be taken to raise preventive and primary healthcare awareness among rural people.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 4","pages":"Article 100731"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48926968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the moderating effect of COVID-19 on Pakistan's healthcare sector 调查2019冠状病毒病对巴基斯坦医疗保健部门的缓和作用
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-08-01 DOI: 10.1016/j.hlpt.2025.101040
Saqib Mehmood , Samera Nazir , Jianqiang Fan (Vice Dean) , Zarish Nazir (MS Scholar) , Sana Nazir (MSs Scholar)

Background

The COVID-19 pandemic has drastically disrupted health service delivery, particularly in resource-limited countries such as Pakistan. This study aims to assess how Pakistan's healthcare infrastructure has adapted in response to the pandemic, focusing on governmental strategies, technology integration, and socioeconomic factors influencing public health outcomes.

Materials and Methods

A stratified random sampling approach was employed, distributing 300 questionnaires to management and staff across hospitals in Punjab. The data collected were analyzed using PLS-SEM4 software to uncover the relationships among the variables of interest.

Results

The findings reveal the complex impacts of the pandemic on healthcare delivery. Effective government regulations were identified as crucial in managing the crisis, while technology integration emerged as a key factor in enhancing healthcare services. Socioeconomic conditions were found to significantly affect public health outcomes, underscoring the interconnection of these components.

Conclusion

This study provides valuable insights for policymakers, healthcare professionals, and researchers aiming to strengthen the resilience of Pakistan's healthcare system. By applying resilience theory, public health policy theory, and complex adaptive systems theory, the research emphasizes the need for adaptability, effective governance, and systemic interconnection in addressing public health challenges. The implications extend globally, offering strategies to improve healthcare infrastructure during crises.
COVID-19大流行严重扰乱了卫生服务的提供,特别是在巴基斯坦等资源有限的国家。本研究旨在评估巴基斯坦的医疗基础设施如何适应疫情,重点关注政府战略、技术整合和影响公共卫生结果的社会经济因素。材料与方法采用分层随机抽样的方法,向旁遮普省各医院的管理人员和工作人员发放了300份问卷。收集的数据使用PLS-SEM4软件进行分析,以揭示感兴趣的变量之间的关系。结果研究结果揭示了疫情对医疗服务的复杂影响。有效的政府法规被认为是管理危机的关键,而技术整合则成为加强医疗保健服务的关键因素。研究发现,社会经济条件显著影响公共卫生结果,强调了这些组成部分的相互联系。本研究为决策者、医疗保健专业人员和旨在加强巴基斯坦医疗保健系统弹性的研究人员提供了有价值的见解。通过运用弹性理论、公共卫生政策理论和复杂适应系统理论,强调应对公共卫生挑战需要适应性、有效治理和系统互联。其影响延伸至全球,提供了在危机期间改善医疗基础设施的战略。
{"title":"Investigating the moderating effect of COVID-19 on Pakistan's healthcare sector","authors":"Saqib Mehmood ,&nbsp;Samera Nazir ,&nbsp;Jianqiang Fan (Vice Dean) ,&nbsp;Zarish Nazir (MS Scholar) ,&nbsp;Sana Nazir (MSs Scholar)","doi":"10.1016/j.hlpt.2025.101040","DOIUrl":"10.1016/j.hlpt.2025.101040","url":null,"abstract":"<div><h3>Background</h3><div>The COVID-19 pandemic has drastically disrupted health service delivery, particularly in resource-limited countries such as Pakistan. This study aims to assess how Pakistan's healthcare infrastructure has adapted in response to the pandemic, focusing on governmental strategies, technology integration, and socioeconomic factors influencing public health outcomes.</div></div><div><h3>Materials and Methods</h3><div>A stratified random sampling approach was employed, distributing 300 questionnaires to management and staff across hospitals in Punjab. The data collected were analyzed using PLS-SEM4 software to uncover the relationships among the variables of interest.</div></div><div><h3>Results</h3><div>The findings reveal the complex impacts of the pandemic on healthcare delivery. Effective government regulations were identified as crucial in managing the crisis, while technology integration emerged as a key factor in enhancing healthcare services. Socioeconomic conditions were found to significantly affect public health outcomes, underscoring the interconnection of these components.</div></div><div><h3>Conclusion</h3><div>This study provides valuable insights for policymakers, healthcare professionals, and researchers aiming to strengthen the resilience of Pakistan's healthcare system. By applying resilience theory, public health policy theory, and complex adaptive systems theory, the research emphasizes the need for adaptability, effective governance, and systemic interconnection in addressing public health challenges. The implications extend globally, offering strategies to improve healthcare infrastructure during crises.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 4","pages":"Article 101040"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144827286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
E-Prescription: A practical application of information and communications technology in perspective of Bangladesh 电子处方:从孟加拉国的角度看信息和通信技术的实际应用
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-08-01 DOI: 10.1016/j.hlpt.2023.100810
M. A. Khan, Md. Rabiul Islam, Asif Rahman, Afsana Mim, Rasel Ahmmed

Objectives

The healthcare management authorities are responsible for delivering convenient services to the patients. The traditional healthcare management system is quite old and impractical in many cases, including a physical visit. Additionally, the COVID-19 epidemic makes the existing system unattainable, which creates an uncomfortable situation for visiting doctor's chambers that is risky both for doctors and patients. An electronic-prescription (e-prescription) management system can switch the existing one to the online appointment and doctor consulting system. Many developed countries have already adopted such e-prescription management systems, although low-and-middle-income countries (LMICs) like Bangladesh are apathetic. So implementing e-prescription management systems in all countries, including Bangladesh, is the demand of time, especially when information and communication technologies (ICT) are at hand.

Method

We design, develop and test an ICT-based online doctor and patient management system utilizing the latest software and web development tools.

Results

In the developed e-prescription management system, the patient can visit their profile to make an appointment according to their need and doctor's availability. After that, the patient consults with the doctor based on the appointment's approval by the admin panel. Finally, the patient receives an online e-prescription and collects the medicine from a registered pharmacy with access to the online e-prescription. The e-prescription management system records patient history, including e-prescription, making handling patients easy.

Conclusion

The proper use of the developed e-prescription management system will solve many existing problems of the existing healthcare management system, including many concerns that arise due to the advent of COVID-19.
目的医疗管理机构有责任为患者提供便捷的服务。传统的医疗保健管理系统在很多情况下都是相当陈旧和不切实际的,包括身体检查。再加上新型冠状病毒感染症(COVID-19)的扩散,使现有的制度变得难以实现,这给医生和患者带来了很大的风险。电子处方管理系统可以将现有的电子处方管理系统转换为网上预约和医生咨询系统。许多发达国家已经采用了这种电子处方管理系统,尽管孟加拉国等低收入和中等收入国家对此漠不关心。因此,在包括孟加拉国在内的所有国家实施电子处方管理系统是时间的要求,特别是在掌握信息和通信技术(ICT)的情况下。方法利用最新的软件和web开发工具,设计、开发和测试基于信息通信技术的在线医患管理系统。结果在开发的电子处方管理系统中,患者可以根据自己的需要和医生的空闲时间访问个人档案进行预约。之后,患者根据管理小组批准的预约向医生咨询。最后,患者收到在线电子处方,并从可访问在线电子处方的注册药房取药。电子处方管理系统记录了患者的历史,包括电子处方,使处理患者变得容易。结论开发的电子处方管理系统的正确使用,将解决现有医疗管理系统存在的诸多问题,包括新冠肺炎疫情带来的诸多担忧。
{"title":"E-Prescription: A practical application of information and communications technology in perspective of Bangladesh","authors":"M. A. Khan,&nbsp;Md. Rabiul Islam,&nbsp;Asif Rahman,&nbsp;Afsana Mim,&nbsp;Rasel Ahmmed","doi":"10.1016/j.hlpt.2023.100810","DOIUrl":"10.1016/j.hlpt.2023.100810","url":null,"abstract":"<div><h3>Objectives</h3><div>The healthcare management authorities are responsible for delivering convenient services to the patients. The traditional healthcare management system is quite old and impractical in many cases, including a physical visit. Additionally, the COVID-19 epidemic makes the existing system unattainable, which creates an uncomfortable situation for visiting doctor's chambers that is risky both for doctors and patients. An electronic-prescription (e-prescription) management system can switch the existing one to the online appointment and doctor consulting system. Many developed countries have already adopted such e-prescription management systems, although low-and-middle-income countries (LMICs) like Bangladesh are apathetic. So implementing e-prescription management systems in all countries, including Bangladesh, is the demand of time, especially when information and communication technologies (ICT) are at hand.</div></div><div><h3>Method</h3><div>We design, develop and test an ICT-based online doctor and patient management system utilizing the latest software and web development tools.</div></div><div><h3>Results</h3><div>In the developed e-prescription management system, the patient can visit their profile to make an appointment according to their need and doctor's availability. After that, the patient consults with the doctor based on the appointment's approval by the admin panel. Finally, the patient receives an online e-prescription and collects the medicine from a registered pharmacy with access to the online e-prescription. The e-prescription management system records patient history, including e-prescription, making handling patients easy.</div></div><div><h3>Conclusion</h3><div>The proper use of the developed e-prescription management system will solve many existing problems of the existing healthcare management system, including many concerns that arise due to the advent of COVID-19.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 4","pages":"Article 100810"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134934267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying pharmaceutical and medical device industry-physician financial ties: An analysis of honorarium payments to Japanese medical association leadership between 2019 and 2021 量化制药和医疗器械行业-医生的财务关系:2019年至2021年日本医学协会领导层的酬金支付分析
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-07-28 DOI: 10.1016/j.hlpt.2025.101081
Akemi Hara , Tetsuya Tanimoto , Piotr Ozieranski , James Larkin , Michioki Endo , Hiroaki Saito , Akihiko Ozaki

Objective

To assess the extent and distribution of pharmaceutical and medical device industry honorarium payments to medical association leadership, enhancing our understanding of industry-physician financial ties in Japan.

Methods

We conducted a retrospective analysis of publicly disclosed payment data from pharmaceutical companies affiliated with the Japan Pharmaceutical Manufacturers Association and medical device companies affiliated with the Medical Devices Network. Data covered honorarium payments for speaking, writing, and consulting to board members of 18 major professional medical associations from 2019 to 2021.

Results

Of the 399 executive board members, 373 (93.5 %) received payments totaling $15.99 million. The median payment per member over the three years was $22,529, (interquartile range [IQR], $7230.8–$57,223.9). Payments were concentrated, with four professional medical associations—representing Internal Medicine ($2.97 million), Ophthalmology ($1.78 million), Dermatology ($1.78 million), and Urology ($1.87 million)—accounting for 52.5 % of the total. Surgical specialties received a higher proportion of payments from medical device companies, while non-surgical specialties – pharmaceutical companies. Payments declined in 2020, coinciding with the COVID-19 pandemic, recovering by 2021. None of the 18 associations' leadership publicly disclosed their board members' financial ties.

Conclusions

We found extensive and concentrated ties between industry and medical association leadership in Japan, with the pharmaceutical and medical device sectors each displaying distinctive payment patterns. The substantial scale of payments and limited transparency displayed by the association highlight the urgent need for legally mandated disclosure, including specialty-specific solutions.
目的评估制药和医疗器械行业向医疗协会领导支付酬金的程度和分布,增强我们对日本行业-医生财务关系的了解。方法回顾性分析日本医药工业协会所属制药公司和医疗器械网络所属医疗器械公司公开披露的支付数据。数据涵盖了2019年至2021年期间向18个主要专业医学协会董事会成员支付的演讲、写作和咨询酬金。结果在399名执行董事会成员中,373名(93.5%)获得了总计1599万美元的薪酬。每位会员在三年内支付的中位数为22,529美元(四分位数区间[IQR]为7230.8美元至57,223.9美元)。付款集中在四个专业医学协会,分别代表内科(297万美元)、眼科(178万美元)、皮肤科(178万美元)和泌尿科(187万美元),占总数的52.5%。外科专业从医疗器械公司获得的付款比例较高,而非外科专业-制药公司。在2019冠状病毒病大流行期间,支付额在2020年下降,到2021年恢复。18家协会的领导层都没有公开披露其董事会成员的财务关系。我们发现日本的行业和医疗协会领导层之间存在广泛而集中的联系,制药和医疗器械行业各自表现出独特的支付模式。该协会所显示的巨额支付和有限的透明度凸显了法律强制披露的迫切需要,包括专门的解决方案。
{"title":"Quantifying pharmaceutical and medical device industry-physician financial ties: An analysis of honorarium payments to Japanese medical association leadership between 2019 and 2021","authors":"Akemi Hara ,&nbsp;Tetsuya Tanimoto ,&nbsp;Piotr Ozieranski ,&nbsp;James Larkin ,&nbsp;Michioki Endo ,&nbsp;Hiroaki Saito ,&nbsp;Akihiko Ozaki","doi":"10.1016/j.hlpt.2025.101081","DOIUrl":"10.1016/j.hlpt.2025.101081","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the extent and distribution of pharmaceutical and medical device industry honorarium payments to medical association leadership, enhancing our understanding of industry-physician financial ties in Japan.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis of publicly disclosed payment data from pharmaceutical companies affiliated with the Japan Pharmaceutical Manufacturers Association and medical device companies affiliated with the Medical Devices Network. Data covered honorarium payments for speaking, writing, and consulting to board members of 18 major professional medical associations from 2019 to 2021.</div></div><div><h3>Results</h3><div>Of the 399 executive board members, 373 (93.5 %) received payments totaling $15.99 million. The median payment per member over the three years was $22,529, (interquartile range [IQR], $7230.8–$57,223.9). Payments were concentrated, with four professional medical associations—representing Internal Medicine ($2.97 million), Ophthalmology ($1.78 million), Dermatology ($1.78 million), and Urology ($1.87 million)—accounting for 52.5 % of the total. Surgical specialties received a higher proportion of payments from medical device companies, while non-surgical specialties – pharmaceutical companies. Payments declined in 2020, coinciding with the COVID-19 pandemic, recovering by 2021. None of the 18 associations' leadership publicly disclosed their board members' financial ties.</div></div><div><h3>Conclusions</h3><div>We found extensive and concentrated ties between industry and medical association leadership in Japan, with the pharmaceutical and medical device sectors each displaying distinctive payment patterns. The substantial scale of payments and limited transparency displayed by the association highlight the urgent need for legally mandated disclosure, including specialty-specific solutions.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 6","pages":"Article 101081"},"PeriodicalIF":3.7,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144830493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The digital equity paradox: When good intentions pave the road to technological stratification 数字公平悖论:当善意为技术分层铺平道路时
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-07-28 DOI: 10.1016/j.hlpt.2025.101079
Y. Tony Yang
{"title":"The digital equity paradox: When good intentions pave the road to technological stratification","authors":"Y. Tony Yang","doi":"10.1016/j.hlpt.2025.101079","DOIUrl":"10.1016/j.hlpt.2025.101079","url":null,"abstract":"","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101079"},"PeriodicalIF":3.7,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144770677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-utility analysis of add-on SGLT2 inhibitors for heart failure with reduced ejection fraction in India 印度附加SGLT2抑制剂治疗心力衰竭伴射血分数降低的成本-效用分析
IF 3.7 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-07-26 DOI: 10.1016/j.hlpt.2025.101077
Akhil Sasidharan , Sajith Kumar S , Suchitralakshmi G , Kavitha Rajsekar , Bhavani Shankara Bagepally

Background

Heart failure with reduced ejection fraction (HFrEF) imposes significant clinical burden and costs in India. While sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated clinical benefits, their cost-effectiveness within the Indian healthcare perspective remains unassessed.

Methods

A Markov model with a lifetime horizon and one-year cycles was developed to evaluate the cost-effectiveness of SGLT2i as an add-on therapy to standard of care (SoC) compared to SoC alone in patients with HFrEF in India. The analysis adopted an abridged societal perspective, incorporating direct medical and non-medical costs, as well as out-of-pocket expenditures. Clinical efficacy data were obtained from meta-analyses while cost data were sourced from published Indian studies and databases. Costs (2024) and Quality-Adjusted Life Years (QALYs) were used to determine the incremental cost-utility ratio (ICURs). A willingness-to-pay (WTP) threshold of one time India’s GDP per capita [₹2,26,765 (US$2,710)] per QALY was used. Uncertainty was assessed through one-way sensitivity analysis (OWSA) and probabilistic sensitivity analysis (PSA). Scenario analyses were conducted to test structural assumptions, and a price threshold analysis was performed to estimate the price at which SGLT2i would become cost-effective.

Results

Despite additional gains in QALYs, add-on SGLT2i were not cost-effective at their current market prices, with an ICUR of ₹6,12,406 (US$7,318) per QALY. Cost-effectiveness estimates were sensitive to variations in drug pricing. PSA confirmed the robustness of these findings. Price threshold analysis indicated that a 71 % reduction in the average market prices for SGLT2i would be required for cost-effectiveness.

Conclusions

While SGLT2i improve clinical outcomes in HFrEF, their current cost renders them not cost-effective in the Indian healthcare setting. Substantial price reductions, potentially through price negotiations with manufacturers, are necessary to enhance their affordability and optimize resource allocation for Heart failure management in India.
背景:心力衰竭伴射血分数降低(HFrEF)在印度造成了巨大的临床负担和费用。虽然钠-葡萄糖共转运蛋白-2抑制剂(SGLT2i)已显示出临床益处,但其在印度医疗保健方面的成本效益仍未得到评估。方法建立了一个具有生命周期和一年周期的马尔可夫模型,以评估SGLT2i作为标准治疗(SoC)的附加治疗与单独使用SoC在印度HFrEF患者中的成本效益。该分析采用了简略的社会观点,纳入了直接医疗和非医疗费用以及自付费用。临床疗效数据来自荟萃分析,而成本数据来自已发表的印度研究和数据库。使用成本(2024年)和质量调整寿命年(QALYs)来确定增量成本效用比(ICURs)。每个QALY的支付意愿(WTP)阈值为印度人均GDP的一倍[2,26,765卢比(2,710美元)]。通过单向敏感性分析(OWSA)和概率敏感性分析(PSA)评估不确定性。进行情景分析以检验结构假设,并进行价格阈值分析以估计sgltti具有成本效益的价格。结果尽管QALY有额外的收益,但附加的SGLT2i在目前的市场价格上并不具有成本效益,每个QALY的ICUR为6,12,406卢比(7,318美元)。成本效益估计对药品定价的变化很敏感。PSA证实了这些发现的稳健性。价格阈值分析表明,SGLT2i的平均市场价格需要降低71%才能达到成本效益。结论:虽然SGLT2i改善了HFrEF的临床结果,但其目前的成本使其在印度医疗保健环境中不具有成本效益。在印度,有必要通过与制造商进行价格谈判来大幅降低价格,以提高他们的负担能力,并优化心力衰竭管理的资源配置。
{"title":"Cost-utility analysis of add-on SGLT2 inhibitors for heart failure with reduced ejection fraction in India","authors":"Akhil Sasidharan ,&nbsp;Sajith Kumar S ,&nbsp;Suchitralakshmi G ,&nbsp;Kavitha Rajsekar ,&nbsp;Bhavani Shankara Bagepally","doi":"10.1016/j.hlpt.2025.101077","DOIUrl":"10.1016/j.hlpt.2025.101077","url":null,"abstract":"<div><h3>Background</h3><div>Heart failure with reduced ejection fraction (HFrEF) imposes significant clinical burden and costs in India. While sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated clinical benefits, their cost-effectiveness within the Indian healthcare perspective remains unassessed.</div></div><div><h3>Methods</h3><div>A Markov model with a lifetime horizon and one-year cycles was developed to evaluate the cost-effectiveness of SGLT2i as an add-on therapy to standard of care (SoC) compared to SoC alone in patients with HFrEF in India. The analysis adopted an abridged societal perspective, incorporating direct medical and non-medical costs, as well as out-of-pocket expenditures. Clinical efficacy data were obtained from meta-analyses while cost data were sourced from published Indian studies and databases. Costs (2024) and Quality-Adjusted Life Years (QALYs) were used to determine the incremental cost-utility ratio (ICURs). A willingness-to-pay (WTP) threshold of one time India’s GDP per capita [₹2,26,765 (US$2,710)] per QALY was used. Uncertainty was assessed through one-way sensitivity analysis (OWSA) and probabilistic sensitivity analysis (PSA). Scenario analyses were conducted to test structural assumptions, and a price threshold analysis was performed to estimate the price at which SGLT2i would become cost-effective.</div></div><div><h3>Results</h3><div>Despite additional gains in QALYs, add-on SGLT2i were not cost-effective at their current market prices, with an ICUR of ₹6,12,406 (US$7,318) per QALY. Cost-effectiveness estimates were sensitive to variations in drug pricing. PSA confirmed the robustness of these findings. Price threshold analysis indicated that a 71 % reduction in the average market prices for SGLT2i would be required for cost-effectiveness.</div></div><div><h3>Conclusions</h3><div>While SGLT2i improve clinical outcomes in HFrEF, their current cost renders them not cost-effective in the Indian healthcare setting. Substantial price reductions, potentially through price negotiations with manufacturers, are necessary to enhance their affordability and optimize resource allocation for Heart failure management in India.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 6","pages":"Article 101077"},"PeriodicalIF":3.7,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144772788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Policy and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1